| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MRSN (MRSN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. MRSN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| VP | 0 | - | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | Mandelia Ashish | VP, Chief Accounting Officer | Sale+OE | 5,025 | $2.71 | $13,617.75 | -17.7% | |
| Jan 16, 2024 | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | Sale+OE | 10,409 | $2.71 | $28,208.39 | -5.0% | |
| Jan 16, 2024 | Deschuytner Brian | SVP, COO &CFO | Sale+OE | 9,327 | $2.71 | $25,276.17 | -14.6% | |
| Jan 16, 2024 | Bala Mohan | SVP, Chief Development Officer | Sale+OE | 3,431 | $2.71 | $9,298.01 | -19.6% | |
| Oct 26, 2023 | Bala Mohan | SVP, Chief Development Officer | Sale+OE | 1,912 | $1.13 | $2,160.56 | -18.0% | |
| Aug 17, 2023 | Misra Tushar | SVP, Chief Manuf. Officer | Sale+OE | 1,908 | $1.18 | $2,251.44 | -14.2% | |
| Apr 27, 2023 | Carvajal Alejandra | SVP, Chief Legal Officer | Sale+OE | 3,944 | $3.89 | $15,342.16 | -16.3% | |
| Jan 17, 2023 | Protopapas Anna | President &CEO | Sale+OE | 17,346 | $5.74 | $99,566.04 | -26.3% | |
| Jan 17, 2023 | Mandelia Ashish | VP, Controller | Sale+OE | 3,575 | $5.74 | $20,520.50 | -20.8% | |
| Jan 17, 2023 | Yang Arvin | SVP, Chief Medical Officer | Sale+OE | 2,209 | $5.74 | $12,679.66 | -6.7% |